• Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
Restless Legs Syndrome: What Changed - When the Medication Starts to Fail, the Iron Test Nobody Offers, and the 2025 Guidelines That Reversed Twenty Y

Restless Legs Syndrome: What Changed - When the Medication Starts to Fail, the Iron Test Nobody Offers, and the 2025 Guidelines That Reversed Twenty Y

Paperback

Series: Neurology, Plainly

Health GeneralMedical Reference

ISBN13: 9798173124241
Publisher: Independently Published
Published: Sep 9 2026
Pages: 156
Weight: 0.48
Height: 0.36 Width: 6.00 Depth: 9.00
Language: English
In January 2025, the guidelines reversed. Most patients have not been told.

For twenty years, the first drug offered for restless legs syndrome was a dopamine agonist. In 2025 the American Academy of Sleep Medicine issued a clinical practice guideline that recommends against using them as standard first-line treatment - and recommends, instead, the alpha-2-delta ligands and intravenous iron.

Also from

Guak, Tae Ho

Also in

Health General